Company Search:
Advanced Search
Sponsored Links
Norda ASA Company Snapshot
Norda ASA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Norda ASA with three other pharmaceutical manufacturers in Europe: Onxeo SA of France (2015 sales of 3.48 million Euro [US$3.79 million] of which 88% was Orphan Products Oncology), Nattopharma ASA (31.69 million Norwegian Kroner [US$3.84 million] of which 100% was Vitamin K2/MenaQ7), and Santhera Pharmaceuticals Holding AG which is based in Switzerland (4.32 million Swiss Francs [US$4.36 million] of which 100% was Pharmaceutical Products).

Sales Analysis. Norda ASA reported sales of NOK 38.76 million (US$4.69 million) for the year ending December of 2015. This represents an increase of 110.6% versus 2014, when the company's sales were NOK 18.41 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Norda ASA
  Stock Performance Chart for Norda ASA
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 8.00
(Figures in Norwegian Kroner)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks n/a   52 Weeks 23.1%  
Norda ASA Key Data:
  Ticker: NORD Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 38,761,179
(Year Ending Jan 2016).
  Currency: Norwegian Kroner Market Cap: 40,258,616
  Fiscal Yr Ends: December Shares Outstanding: 5,032,327
  Share Type: Ordinaere Aksje Closely Held Shares: 2,259,375
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.